(Q43618512)

25 November 2017

title

A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoid (English)

1 reference

25 November 2017

Le Buanec H

1

1 reference

25 November 2017

Lachgar A

2

1 reference

25 November 2017

Bizzini B

3

1 reference

25 November 2017

Zagury JF

4

1 reference

25 November 2017

Rappaport J

5

1 reference

25 November 2017

Santagostino E

6

1 reference

25 November 2017

Muça-Perja M

7

1 reference

25 November 2017

Gringeri A

8

1 reference

25 November 2017

publication date

1 January 1998

1 reference

Biomedicine and Pharmacotherapy

25 November 2017

published in

1 reference

25 November 2017

volume

52

1 reference

25 November 2017

issue

10

1 reference

25 November 2017

page(s)

431-435

1 reference

New human and simian HIV-related retroviruses possess functional transactivator (tat) gene

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Neurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Antiproliferative action of interferon-α requires components of T-cell-receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Tat toxoid as a component of a preventive vaccine in seronegative subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2899%2980020-1

7 January 2021

10.1016/S0753-3322(99)80020-1

Identifiers

DOI

1 reference

25 November 2017

1 reference